NLS
May 24, 2018
We want to assure you that we process your personal data in accordance with the GDPR.
Published: May 24, 2018
Top stories
Biotech Business – September 22, 2026
Elicera Therapeutics has received approval from the Swedish Medical Products Agency (Läkemedelsverket) to move its CARMA study of the CAR T-cell therapy ELC-301 in B-cell lymphoma into Phase IIa.
Business article – September 22, 2026
A new study co-authored by Jonathan Ilicki, Life Science Strategy Lead at the Swedish venture capital firm Industrifonden, finds that investment and business-development professionals often misjudge rare-disease assets, underestimating launch performance and misreading when the assets are most commonly acquired.
Profiles in Business – September 22, 2026
Throughout her career, customer centricity and a passion for solving unmet medical needs have driven Norwegian Lena Nymo Helli. This year, she joined the Danish company Coloplast as Country Manager for Norway.
Global report – September 21, 2026
US President Donald Trump said on Friday September 18, 2026, that his administration plans to recommend that vaccine makers split certain childhood vaccines into five smaller doses given six months apart, which he expects to sharply reduce autism. He did not name the vaccines or cite evidence.
Related posts
Collaboration - September 16, 2026
A Swedish healthcare delegation traveled to Kyiv on September 2–4 to strengthen cooperation on rebuilding Ukraine's healthcare system, timed to one of the most difficult periods for the city in months.
Collaboration - September 15, 2026
The Novo Nordisk Foundation (NNF) and NordForsk have signed a framework agreement to fund Nordic research co-operation over the period 2026–2030.
Collaboration - September 14, 2026
RaySearch Laboratories and US-based Accuray have entered a definitive agreement to expand their collaboration on online adaptive radiation therapy, with Accuray committing to purchase RayStation software licences worth USD 8 million.
Collaboration - September 8, 2026
Vienna-based HeartBeat.bio and Stockholm-based Cubase Bio have been awarded roughly EUR 1 million in Eurostars funding to develop a 3D spatial profiling method for studying myocardial fibrosis and heart failure, combining human cardiac organoids with true 3D spatial transcriptomics technology.
Klaria has entered a collaboration agreement with RTHS to combine RTHS's sensor-based measurements of blood flow dynamics with Klaria's approved migraine treatment, aiming to detect migraine attacks before symptoms set in.
Collaboration - September 4, 2026
The BioInnovation Institute (BII) and GU Ventures (GUV) are collaborating to strengthen the regions' competitiveness in life science, a project funded by Interreg Öresund-Kattegat-Skagerrak and Region Västra Götaland.
Business article - September 2, 2026
Europe has the science. What it doesn't have is the capital, and industry leaders warn that gap is pushing the region's most promising biotechs to scale up in the US instead.
This site uses cookies
Read more about our privacy policy
The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.
The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.
The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.